Electric vehicle (EV) stocks are in a tizzy, communicated by Tesla’s (NASDAQ:TSLA) more than 40% year-to-date slump. If that doesn’t provide enough evidence, consider the Global X Autonomous & Electric Vehicles ETF‘s (NASDAQ:DRIV) near 10% year-to-date drawdown. Although recent results show that EV stocks are under pressure, key metrics indicate numerous EV stocks are oversold. For

As the market pulls back in April, it’s time to put some dry powder to work. Some of the top Nasdaq stocks have pulled back significantly and present opportunities at current levels. After a 25% rally since November 2023, when the market barely had any pullback, a bigger correction was in the cards. It appears

Consumers and small businesses need easy access to cash for important purchases. Fintech companies offer these services and several perks to entice individuals to work with them over the competition. The industry has gotten more competitive as digital banks and fintech companies have sprouted up. Financial institutions no longer need vast networks to compete if

In a bull market, the role of blue-chip stocks is often understated. Investors look for growth stocks with millionaire-maker potential. However, when markets are volatile or trending lower, blue-chip stocks are a fortress for the portfolio. With relatively volatile market conditions, this column discusses three undervalued blue-chip dividend stocks to consider. It’s worth noting that

The U.S. economy holds promise with the rapid growth of robotics stocks and automation across industries. Companies increasingly invest in automated systems, expecting significant improvements in output quality, efficiency and uptime. The retail and consumer goods sector, in particular, is poised to lead this automation wave, with substantial capital allocations planned over the next five

The majority of leading global indices reached new highs in 2024, fueled by loose financial conditions and burgeoning enthusiasm for artificial intelligence (AI). In the U.S., this rally pushed the S&P 500 to fresh highs. And unwavering investor optimism and the prospect of stocks joining the trillion-dollar club maintained the surge. Historically, the markets prefer

When dealing with speculative investments – especially overlooked penny stocks – prospective participants must first acknowledge the risks. It’s a wild world out there. Anything can happen and if I may be blunt, that “anything” tends to be something bad. Unfortunately, if you choose 10 overlooked penny stocks, having two of them be winners is

There’s a proverb that states idle hands are the devil’s workshop, which makes sin stocks so compelling. Humans engage in certain practices, whether that involves imbibing or gambling as a means to let off some steam. Yes, the concept undergirding sin stocks is controversial. I don’t think there’s any way of getting around this reality.

Artificial intelligence is a big business and it will likely get bigger, possibly boding well for AI penny stocks. While extremely speculative, these ideas present enormous upside potential. They could be ideal for those who can stomach extreme volatility. Now, let me just be straightforward. AI penny stocks are akin to knife fights. When you

Enterprises of all sizes are increasingly leveraging the combined power of cloud computing and AI. Forecast growth is high, making AI cloud stocks a strong investment consideration. Cloud providers continue to integrate AI functionality within their respective cloud platforms. These integrations will lead to automation, self maintenance and increased data analysis capabilities. It all suggests that

Electric vehicle (EV) charging stocks are rising as federal legislation promotes the construction and standardization of U.S. EV charging infrastructure. The Bipartisan Infrastructure Law proposes a $7.5 billion national EV charging network to promote electric cars. By 2030, the bill aims for 500,000 public chargers and a reliable network. To promote EVs and infrastructure, the

Investors accumulate growth stocks with the hopes of outperforming the stock market. Some of these investments produce substantial returns for patient investors, but the key is sticking with successful corporations over the long run. Some investors sell their shares too early and miss out on significant gains. While it makes sense to sell shares in

The stock market is facing some unique challenges at this point. For starters, the specter of inflation continues to push back the timelines for interest rate cuts that many had anticipated by now. Then there’s the incredibly uncertain geopolitical situation due to the Ukraine and Middle East conflict. Furthermore, the artificial intelligence (AI) catalyst hasn’t

The case for multibagger solar stocks is not particularly convincing at this point. One of the biggest reasons for the shift is California’s new net metering policies, which make it significantly less attractive for Californian residents to send surplus electricity back to the grid. Furthermore, you have the rising interest rates diminishing the value of

Investing in biotech stocks is not for the faint of heart. The sector is prone to wild swings in stock prices, offering a distinctive blend of high risk and high reward. The companies in the biotech space are consistently pushing the envelope, making them excellent investment opportunities in a perfect storm situation. One of the

For investors, identifying strong strategic potential is necessary for spotting profitable investment prospects. Bearing this in mind, three businesses are captivating the attention of astute investors, offering an attractive chance to create millionaire stocks. These businesses have established strong market positions through calculated risks that should yield generous rewards. The first business, for instance, has

Marijuana legalization may be inching closer in the U.S. but it just became a reality in Germany. As of April 1, Germans can now legally grow up to three marijuana plants for personal use. They can also possess up to 50 grams at home and up to 25 grams in public.  Starting July 1, people

The economy is currently on a stable trajectory and is poised for sustained growth; the indicators show a positive outlook overall. However, the biotech industry presents even more compelling potential, demonstrating a compounding annual growth rate (CAGR) of 13.96% from 2024 to 2030. This substantial growth is largely attributed to robust government support and the